Aleafia Health (DB:ARAH) - Aandelenkoers, Nieuws & Analyse

ARAH Overzicht aandelen

Aleafia Health Inc., together with its subsidiaries, operates as cannabis health and wellness company in Canada, Europe, and Australia. Meer informatie

ARAH fundamentele analyse
Sneeuwvlok Score
Waardering	2/6
Toekomstige groei	0/6
Prestaties in het verleden	0/6
Financiële gezondheid	0/6
Dividenden	0/6

Risicoanalyse

De winst is de afgelopen 5 jaar met 30% per jaar gedaald

Heeft geen betekenisvolle marktkapitalisatie ( €8M )

Negatief eigen vermogen

Aandelen zijn zeer illiquide

+ 1 meer risico

Aleafia Health Inc. Concurrenten

Biofrontera

XTRA:B8FK

€16.1m

SynBiotic

DUSE:SBX

€27.9m

Cantourage Group

XTRA:HIGH

€57.6m

Redx Pharma

DB:0RX

€65.0m

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Aleafia Health
Historische aandelenkoersen
Huidige aandelenkoers	CA$0.015
52 Week Hoogtepunt	CA$0.079
52 Week Laag	CA$0.0005
Bèta	1.73
11 maand verandering	0%
3 maanden verandering	3,000.00%
1 Jaar Verandering	-50.79%
33 jaar verandering	-94.60%
5 jaar verandering	-97.67%
Verandering sinds IPO	-96.70%

Recent nieuws en updates

Recent updates

Rendement voor aandeelhouders

	ARAH	DE Pharmaceuticals	DE Markt
7D	0%	1.6%	1.1%
1Y	-50.8%	-19.0%	7.2%

Rendement versus industrie: ARAH presteerde slechter dan de German Pharmaceuticals -sector, die het afgelopen jaar een rendement van -19 % opleverde.

Rendement versus markt: ARAH presteerde slechter dan German Market, dat het afgelopen jaar een rendement van 7.2 % opleverde.

Prijsvolatiliteit

Is ARAH's price volatile compared to industry and market?
ARAH volatility
ARAH Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	7.0%
Market Average Movement	4.8%
10% most volatile stocks in DE Market	10.9%
10% least volatile stocks in DE Market	2.4%

Stabiele aandelenkoers: De aandelenkoers van ARAH is de afgelopen 3 maanden volatiel geweest.

Volatiliteit in de loop van de tijd: Onvoldoende gegevens om de volatiliteitsverandering van ARAH in het afgelopen jaar te bepalen.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
n/a	158	Tricia Symmes	www.aleafiahealth.com

Aleafia Health Inc. Samenvatting

Hoe verhouden de winst en inkomsten van Aleafia Health zich tot de beurswaarde?
ARAH fundamentele statistieken
Marktkapitalisatie	€5.48m
Inkomsten(TTM)	-€23.53m
Inkomsten(TTM)	€29.13m

0.2x

P/S-verhouding

-0.2x

Koers/Winstverhouding

Is ARAH overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
ARAH resultatenrekening (TTM)
Inkomsten	CA$42.85m
Kosten van inkomsten	CA$36.85m
Brutowinst	CA$6.00m
Overige uitgaven	CA$40.61m
Inkomsten	-CA$34.61m

Laatst gerapporteerde inkomsten

Mar 31, 2023

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	-0.086
Brutomarge	14.00%
Nettowinstmarge	-80.77%
Schuld/Eigen Vermogen Verhouding	-499.1%

Hoe presteerde ARAH op de lange termijn?

Bekijk historische prestaties en vergelijking

ARAH Overzicht aandelen

Risicoanalyse

Aleafia Health Inc. Concurrenten

XTRA:B8FK

€16.1m

DUSE:SBX

€27.9m

XTRA:HIGH

€57.6m

DB:0RX

€65.0m

Prijsgeschiedenis en prestaties

Recent nieuws en updates

Red White & Bloom Brands Inc. (CNSX:RWB) completed the acquisition of One Plant (Retail) Corp. and Certain assets of Aleafia Health Inc. for $31.7 million.

Red White & Bloom Brands Inc. (CNSX:RWB) acquired Certain assets of Aleafia Health Inc. for $31.6677 million.

Red White & Bloom Brands Inc. (CNSX:RWB) entered into a stalking horse asset purchase agreement to acquire Certain assets of Aleafia Health Inc.

Aleafia Health Obtains Creditor Protection to Pursue Restructuring and Sale Process

New major risk - Financial position

Full year 2023 earnings released: CA$0.09 loss per share (vs CA$0.42 loss in FY 2022)

Recent updates

Red White & Bloom Brands Inc. (CNSX:RWB) completed the acquisition of One Plant (Retail) Corp. and Certain assets of Aleafia Health Inc. for $31.7 million.

Red White & Bloom Brands Inc. (CNSX:RWB) acquired Certain assets of Aleafia Health Inc. for $31.6677 million.

Red White & Bloom Brands Inc. (CNSX:RWB) entered into a stalking horse asset purchase agreement to acquire Certain assets of Aleafia Health Inc.

Aleafia Health Obtains Creditor Protection to Pursue Restructuring and Sale Process

New major risk - Financial position

Full year 2023 earnings released: CA$0.09 loss per share (vs CA$0.42 loss in FY 2022)

Red White & Bloom Brands Inc. (CNSX:RWB) entered into a binding letter agreement to acquire Aleafia Health Inc. (TSX:AH) from shareholders for CAD 74.98 million.

High number of new and inexperienced directors

Third quarter 2023 earnings released: CA$0.062 loss per share (vs CA$0.22 loss in 3Q 2022)

Aleafia Health Inc. to Report Q3, 2023 Results on Feb 08, 2023

Now 33% undervalued

Aleafia Health Inc. Announces Board Changes

Now 36% undervalued after recent price drop

High number of new and inexperienced directors

High number of new and inexperienced directors

Aleafia Health Inc. to Report Q2, 2023 Results on Nov 09, 2022

Aleafia Health Expands Sunday Market House of Brands with Coveted Lineup of Winter Product Launches

Aleafia Health Announces TSX Decision to Extend Delisting Review Period to November 29, 2022

Aleafia Health Inc. to Report Q2, 2022 Results on Aug 11, 2022

Aleafia Health Inc., Annual General Meeting, Sep 27, 2022

High number of new and inexperienced directors

Full year 2022 earnings released: CA$0.42 loss per share (vs CA$0.84 loss in FY 2021)

Aleafia Health Inc. Reaffirms Revenue Guidance for the Fiscal Year 2023

Aleafia Health Inc. announced that it has received CAD 5.6225 million in funding

High number of new and inexperienced directors

Aleafia Health Inc. announced that it expects to receive CAD 5.6225 million in funding

High number of new and inexperienced directors

Aleafia Health Inc. Reaffirms Earnings Guidance for the Fiscal Year 2022

Aleafia Health Inc. Announces Impairment of Property, Plant & Equipment for the Fourth Quarter Ended December 31, 2021

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Aleafia Health Inc. to Report Q4, 2021 Results on Feb 14, 2022

Aleafia Health Inc. Announces Executive Changes

Third quarter 2021 earnings released: CA$0.25 loss per share (vs CA$0.066 loss in 3Q 2020)

High number of new and inexperienced directors

Aleafia Health Launches Premium Cannabis Brand Nith & Grand

Aleafia Health Expands Bogart’s Kitchen Edibles Portfolio with Launch of Salted Caramel Pretzel Bites

Aleafia Health Inc. Announces It Has Largely Completed Planting Across 86 Acres At Its Outdoor Cultivation Facility in Port Perry, Ont

Aleafia Health Inc. Expands Trailblazing Wellness Brand Noon & Night with Launch of Freshly Minted Roll-On

CFO & Corporate Secretary Benjamin Ferdinand has left the company

Aleafia Health Inc.'s Everyday Cannabis Brand Divvy Launches Large Format Dried Flower Portfolio

First quarter 2021 earnings released: CA$0.036 loss per share (vs CA$0.022 loss in 1Q 2020)

Aleafia Health Inc. Secures Health Canada Research Licence

Full year 2020 earnings released: CA$0.85 loss per share (vs CA$0.18 loss in FY 2019)

Aleafia Health Expands Adult-Use Presence with Entrance in Saskatchewan, New Provincial Market

Aleafia Health Inc. has completed a Composite Units Offering in the amount of CAD 19.92 million.

Aleafia Health Inc. Launches THC Soft Chews Under its Edibles Brand Bogart’s Kitchen

Aleafia Health Inc. to Report Q4, 2020 Results on Mar 25, 2021

Aleafia Health Secures Licence for Toronto Distribution Centre, Expanding Supply Chain and Ecommerce Opportunity

Aleafia Health Inc. Launches Sunday Market House of Brands

New 90-day high: €0.59

Aleafia Health Inc. Announces Directorship Appointments

Aleafia Health Announces Resignation Rhonda Lawson as Director

Unifor and Aleafia Health Enter Exclusive Agreement to Support Medical Cannabis Coverage for Members

Aleafia Health Inc. Enters Definitive Supply Agreement with Apipharm

Unifor and Aleafia Health Inc. Partner on Groundbreaking Medical Cannabis Coverage

New 90-day high: €0.38

Aleafia Health Enters into Supply Agreement with Robes Cannabis Inc

Aleafia Health Launches High Potency CBD 50 Cannabis Oil

Aleafia Health Inc. Launches Kin Slips® Rapid Onset Cannabis-Infused Sublingual Strips

Third quarter 2020 earnings released: CA$0.066 loss per share